Categories: News

Washington Post Features EnvisionBody’s Software Link to Connected Fitness

TAMPA BAY, Fla., Jan. 12, 2021 /PRNewswire/ — Dalvin Brown, innovations reporter for the Washington Post, wrote “A new take on before and after photos is the thought-provoking idea behind EnvisionBody, a Tampa Bay area start-up with patented technology to keep users fixated on a more active version of themselves while running on a treadmill, cycling on a stationary bike or working out in front of a connected mirror.”

You can find the article,  One solution for keeping you motivated during workouts: A digitally enhanced reflection in the Washington Post.

“We should leverage this generation of AR/AI technology to assist people in achieving their fitness goals and I would argue we have a responsibility to do so. Obesity is a heavy burden on our healthcare system,” Salina Ray, says. “Before and after images have been used for years to sell products or services because that is what motivates people to take action”, Ray says. “It makes sense to bring the outdated historic use of before and after still images up to this level of high-tech fitness engagement by utilizing advanced AR/AI technology,” Ray, says.

About EnvisionBody

EnvisionBody serves as an AR & AI multi-patented software tool that integrates with fitness machines and/or weight loss apps; leveraging the latest technology to mitigate the burden of the global obesity epidemic causing strokes, hypertension, cardiac issues, and cancer that is overwhelming our economy.

More information is available at EnvisionBody.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/washington-post-features-envisionbodys-software-link-to-connected-fitness-301206272.html

SOURCE EnvisionBody

Staff

Recent Posts

Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations

TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…

1 hour ago

Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…

1 hour ago